Physicians Committee for Responsible Medicine, Washington, DC, USA.
Physicians Committee for Responsible Medicine, Washington, DC, USA.
Clin Nutr ESPEN. 2021 Feb;41:126-128. doi: 10.1016/j.clnesp.2020.12.012. Epub 2021 Jan 2.
BACKGROUND & AIMS: In the U.S., Blacks as a group have an earlier onset, greater severity, and earlier mortality from cardiovascular disease than their White peers. The aim of this study was to test whether Black and White individuals experience similar cardiovascular risk reduction in response to a dietary intervention.
In the course of a randomized trial assessing the effect of low-fat plant-based dietary intervention on cardiometabolic outcomes in overweight adults, this study compared the effects of a 16-week intervention in Black and White participants.
We randomly assigned 244 participants to the intervention (n = 122, including 60 Blacks and 57 Whites) or control (n = 122, including 53 Blacks and 60 Whites) groups. The full study was completed by 222 (91.0%) participants. There were no significant differences between Blacks and Whites in changes in body mass index (-2.3 kg/m2 in both races; p-value for the difference between Blacks and Whites p = 0.99), insulin resistance (Blacks -1.9, Whites -0.85; p = 0.30), total cholesterol (Blacks -0.73 mmol/L, Whites -0.69 mmol/L p = 0.89), LDL-cholesterol (Blacks -0.59 mmol/L, Whites -0.68 mmol/L p = 0.76), or any other measure.
Our data suggest that a healthful plant-based diet improves measures of cardiometabolic health independent of race.
ClinicalTrials.gov number, NCT02939638.
在美国,黑人整体的心血管疾病发病年龄更早、病情更严重、死亡率更高。本研究旨在检验黑人和白人在接受饮食干预时,心血管风险是否能得到相似程度的降低。
在一项评估低脂植物性饮食干预对超重成年人心脏代谢结局影响的随机试验中,本研究比较了黑人和白人参与者在 16 周干预期间的效果。
我们将 244 名参与者随机分配到干预组(n=122,包括 60 名黑人参与者和 57 名白人参与者)或对照组(n=122,包括 53 名黑人参与者和 60 名白人参与者)。共有 222 名(91.0%)参与者完成了完整的研究。黑人组和白人组的体重指数变化(两组均降低 2.3kg/m2;黑人组和白人组之间的差异 p 值=0.99)、胰岛素抵抗(黑人组-1.9,白人组-0.85;p=0.30)、总胆固醇(黑人组-0.73mmol/L,白人组-0.69mmol/L p=0.89)、LDL-胆固醇(黑人组-0.59mmol/L,白人组-0.68mmol/L p=0.76)或任何其他指标均无显著差异。
我们的数据表明,健康的植物性饮食可改善心脏代谢健康指标,且与种族无关。
ClinicalTrials.gov 编号,NCT02939638。